Streetbeat News

Analyst Ratings

PRQR

Four analysts have provided ratings for ProQR Therapeutics (NASDAQ:PRQR) in the last quarter, with one being bullish, two somewhat bullish, and one indifferent. The average price target given by these analysts is $4.38, compared to the current price of $1.535, implying an upside. However, this average has decreased by 12.4% from the previous average price target of $5.00.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 6:00 pm

QSR

Over the past 3 months, 11 analysts have published their opinion on Restaurant Brands Intl (NYSE:QSR) stock. The average price target for the stock is $80.91, with a high of $89.00 and a low of $73.00. This average price target has increased by 7.56% over the past month.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 6:00 pm

KSS

Over the past 3 months, 11 analysts have published their opinion on Kohl's (NYSE:KSS) stock. The average price target is $24.09, representing a 8.89% decrease from the previous average price target of $26.44.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 6:00 pm

JNJ

Johnson & Johnson Inc. (NYSE:JNJ) stock is currently trading at $171.79, after a 0.67% increase. Over the past month, the stock increased by 7.87%, and in the past year, by 0.89%. The company's P/E ratio is 34.61, lower than the aggregate P/E ratio of 40.51 in the Pharmaceuticals industry. This could indicate that the stock is undervalued or that shareholders do not expect the stock to perform better in the future.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 6:00 pm

PHG

RMD

ResMed Inc (RMD) reported Q4 adjusted EPS of $1.60, missing the consensus of $1.67. Revenues increased 23% to $1.12 billion, driven by increased demand for sleep and respiratory care devices. KeyBanc reiterated the Overweight rating but lowered the price target to $260. Needham kept the Hold rating on the stock. Analysts expect that if Philips (PHG) reenters the market, ResMed's growth could slow. RMD shares are down 17.20% at $182.01.

Portfolio Pulse from Vandana Singh

August 04, 2023 | 6:00 pm

BWXT

BWX Technologies shares are trading higher after the company reported better-than-expected Q2 results. Baird has upgraded the stock to Outperform.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 5:55 pm

BRFS

JP Morgan has upgraded BRF's stock to Overweight, leading to a rise in the company's shares.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 5:53 pm

AMN

AMN Healthcare Services' stock has been downgraded from Buy to Neutral by B of A Securities, leading to a decrease in the share price.

Portfolio Pulse from Benzinga Newsdesk

August 04, 2023 | 5:50 pm

RCL

A significant bearish stance has been taken on Royal Caribbean Gr (NYSE:RCL) by a large investor, as indicated by a large position in options. The sentiment among these big-money traders is 90% bearish and 10% bullish. The whales have been targeting a price range from $50.0 to $106.0 for Royal Caribbean over the last 3 months. Several financial institutions have maintained their ratings on RCL, with price targets ranging from $113 to $132.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 5:46 pm

OXY

A significant bullish stance has been taken on Occidental Petroleum (NYSE:OXY) with 39 uncommon options trades spotted. The sentiment of these big-money traders is split between 64% bullish and 35% bearish. The whales have been targeting a price range from $47.5 to $85.0 for Occidental Petroleum over the last 3 months. The price of OXY is up 3.55% at $64.42. Citigroup downgraded its action to Neutral with a price target of $62, while Raymond James, Morgan Stanley, Susquehanna, and Stephens & Co. maintained their ratings with price targets of $75, $60, $72, and $69 respectively.

Portfolio Pulse from Benzinga Insights

August 04, 2023 | 5:46 pm